Model N Unveils First Revenue Management Platform to Enable Digital Reinvention
Model N, Inc. (NYSE: MODN), the leading provider of revenue management solutions for the Pharmaceutical, Medical Device, High Tech, Manufacturing and Semiconductor industries, today announced the release of the next generation of its Revenue Cloud platform. Revenue Cloud now becomes the first end-to-end platform to enable digital reinvention for companies in these industries.
About Digital Reinvention
Digital disruption has already reduced the average tenure for companies on the S&P 500 list from 33 to 12 years, and only 8% of companies believe their business models will remain viable through digitization. Pharmaceutical, Medical Device, High Tech, Manufacturing and Semiconductor companies face a stark choice: reinvent or perish.
Bold digital reinvention strategies begin with placing customers at the center of companies’ digital activity. Instead of seeing themselves through the internal lens of functions, products, and processes, companies now see themselves through the lens of their customers. These strategies require a deep understanding of unique customer segment needs, business models, revenues, and profitability, and more.
Companies that embark on digital reinvention strategies must do the following:
- Redefine the business they are in
- Redefine who their customers are
- Reinvent their offerings to those customers
- Delight customers in each interaction
- Position themselves in the digital ecosystem
- Realign operations with intelligent internal processes
The Platform for Digital Reinvention
While an offensive platform strategy focused on the demand-side is proven to yield the best results, only 1.5% percent of companies have adopted one, mainly due to the lack of a Digital Reinvention platform.
Model N Revenue Cloud is the first Digital Reinvention platform, designed specifically for Life Sciences, High Tech and Manufacturing companies.
This release of Revenue Cloud includes the following highlights:
- Introduction of Model N CPQ, the next generation of Configure, Price and Quote, which enables companies to reinvent their offerings and their business models
- Introduction of Model N Channel Cloud, an end-to-end solution to manage the digital ecosystem and omni-channel
- Introduction of Revenue Cloud for Semiconductors and Revenue Cloud for Manufacturing
- New versions of Revenue Cloud for Pharma, Revenue Cloud for MedTech, and Revenue Cloud for High-Tech
Introducing Model N CPQ
Model N CPQ is the end-to-end, enterprise-grade platform that bridges the gap between Salesforce and SAP with robustness, performance and scalability that meet the needs of enterprises.
Model N CPQ enables companies to:
- Reinvent their offering to their customers by configuring solutions that are tailored to unique customer needs that include products, software services, data and other elements.
- Align their business with those of their customers’ by leveraging new models such as subscription, outcome base and risk-sharing among others.
- Delight their customers by digitizing their experience with new capabilities, such as self-service.
- Transform internal operations into intelligence processes with new Intelligent Approvals, guided selling, and business intelligence, cutting the process cycle-time to a bare minimum hence significantly enhancing the customer experience.
- Drive business expansion through digital ecosystems and omni-channel.
- Rapidly deploy and execute digital reinvention strategies by interoperating effectively with SAP and SAP Variant Configurator (VC). Marketing and Sales can now start with SAP VC KMAT models as a foundation for new offerings that are tailored to unique customer needs.
- Understand the profitability of a deal, a contract, customers and customer segments with insights that help them understand thoroughly the economics of their digital strategies. Model N CPQ now quotes based on net-price including rebates, Market Development Funds (MDF), and other incentives, not just gross-price.
“Model N next-generation CPQ enables companies to leverage their SAP and SAP VC infrastructure as a stepping stone for their Digital Reinvention strategy.” said Neeraj Gokhale, SVP and Chief Product Officer at Model N. “Creating a new value proposition for customers and aligning the business models with Model N CPQ is enabling companies to grow their top line.”
Introducing Channel Cloud
Embracing the digital ecosystem and omni-channel are paramount to Digital Reinvention. McKinsey research demonstrated that an emerging set of digital ecosystems could account for more than $60 trillion in revenues by 2025, or more than 30 percent of global corporate revenues. In a world of ecosystems, as industry boundaries blur, strategy needs a much broader frame of reference. Current point channel solutions fall significantly short of meeting the sophistication of the ecosystem.
Model N’s new Channel Cloud enables companies to leverage a wide ecosystem that includes global, multi-tier, sophisticated channels as part of their Digital Reinvention. Channel Cloud combines intelligent processes, visibility, sophisticated rewards to align business models, and a comprehensive data platform.
Channel Cloud enables companies to mesh with the digital ecosystem by:
- Driving their channels’ marketing execution to meet their revenue goals with Market Development Funds (MDF) Management. It is the first MDF solution in a fully integrated end-to-end channel solution.
- Establishing a digital ecosystem for channel collaboration with Channel Management. Companies can maximize revenue by avoiding channel conflict and flawlessly executing with the ecosystem.
- Incenting the channel to drive revenues with Rebate Management. Companies can balance discounting decisions and post-deal rebating based on results to optimize revenues.
- Ensuring a single source of truth with Channel Data Management (CDM), putting the entire digital ecosystem on the same page. CDM delivers real-time, accurate, complete channel data, including sales and inventory, enabling transparency and channel performance.
Channel Cloud is offered as part of Revenue Cloud for High Tech, Revenue Cloud for Semiconductors, Revenue Cloud for Manufacturing, and Revenue Cloud for MedTech.
Revenue Cloud Strengthened
In addition to Model N CPQ and the new Channel Cloud solution, Model N is announcing a completely new Revenue Cloud for Semiconductor and Revenue Cloud for Manufacturing suites, and new versions of its Revenue Cloud for Pharma, Revenue Cloud for MedTech, and Revenue Cloud for High Tech suites, to enable Digital Reinvention in those industries. Full details of each new Revenue Cloud solution are available at www.modeln.com or through the media contact listed below.
For more information on Model N Revenue Cloud, please visit modeln.com/products/revenue-cloud .
About Model N
Model N is the leader in Revenue Management solutions. Driving mission-critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world’s leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com. Model N is a registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.
Holly Hagerman, 801-373-7888
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
ResMed-sponsored Studies Show Combining Home Oxygen and Home Non-invasive Ventilation is a Cost Effective Treatment for COPD21.5.2018 00:15 | Tiedote
ResMed (NYSE: RMD, ASX: RMD) announced today the results of two clinical analyses conducted for the U.K. and U.S., demonstrating the cost effectiveness of combining home oxygen therapy and home non-invasive ventilation (NIV) therapy for patients with persistent hypercapnia following a life-threatening exacerbation of chronic obstructive pulmonary disease (COPD). The ResMed-backed Home Oxygen Therapy – Home Mechanical Ventilation (HOT-HMV) health economic studies, presented today at the ATS 2018 International Conference, build on earlier data demonstrating the clinical and cost effectiveness of HOT-HMV therapy (i.e. combining home oxygen therapy with home NIV), compared to treating with oxygen alone. The U.K. study found that HOT-HMV treatment reduced exacerbation frequency and 28-day hospital readmission. The U.S. analysis found a 58.3 percent reduction in 30-day readmissions for HOT-HMV patients compared to those on home oxygen alone – and that HOT-HMV can actually save patients money
WELL Building Standard Gaining Momentum in Europe18.5.2018 17:47 | Tiedote
As Greenbuild Europe came to a close in Berlin, the International WELL Building Institute™ (IWBI™) used the occasion to highlight how the WELL Building Standard™ (WELL™) has elevated health and well-being to the forefront of sustainability conversations across Europe. WELL continues to advance the healthy building movement as the premier standard for buildings, interior spaces and communities seeking to implement, validate and measure features that promote human health and wellness. The resonance of the program has spurred innovations across the building, design and construction industries, providing projects with customizable approaches to address geographical and cultural health concerns. To date, WELL has enrolled more than 830 projects encompassing over 155 million square feet of real estate in 32 countries worldwide. In Europe nearly 190 projects across 13 countries are engaged with WELL, representing 25% of global WELL project square footage. The strong growth of WELL over the pa
Utimaco Announces Intent to Acquire Atalla from Micro Focus18.5.2018 12:03 | Tiedote
Utimaco, the global #2 in Hardware Security Modules (HSMs), today announced the intent to acquire the Atalla HSM and ESKM business lines from Micro Focus, which were previously owned by Hewlett Packard Enterprise (HPE) prior to the September 2017 merger of its Software business with Micro Focus. Germany-based Utimaco, active in the HSM market for over 35 years, is a global manufacturer of general purpose HSMs. Utimaco has built its market leading position focusing on indirect sales through OEM or channel business partners and selling its SecurityServer product line into industries as diverse as automotive, government, media & entertainment, smart metering, semiconductors, telecommunications and the banking and financial services sectors. Utimaco is traditionally strong in its German home market based on its longstanding German banking association certification (DK) and has recently achieved PCI accreditation for the SecurityServer product line. With the acquisition of Atalla, one of th
Janssen to Present New Data in Urothelial, Haematologic and Prostate Cancers at ASCO 2018, including Best of ASCO Selections18.5.2018 10:00 | Tiedote
The Janssen Pharmaceutical Companies of Johnson & Johnson, today announced 21 company-sponsored abstracts will be presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL on June 1-5. New data analyses in support of a portfolio of products, including the investigational treatments erdafitinib and apalutamide, as well as approved treatments Imbruvica® (ibrutinib), Darzalex® (daratumumab), and Zytiga® (abiraterone acetate) will be highlighted across urothelial, haematologic and prostate cancers. Notably, Phase 2 trial results for the investigational compound erdafitinib, which received U.S. Food and Drug Administration (FDA) Breakthrough Therapy Designation, will be presented during an oral presentation on Sunday, June 3 (Abstract #4503).1,2 For haematologic cancers, Phase 3 data from the iNNOVATE study will provide the first look at ibrutinib plus rituximab versus placebo plus rituximab in patients with newly diagnosed and relapsed/refractory Wald
Karisma Hotels & Resorts to Open Allure Palazzi Kotor Bay Hotel by Karisma in June 201818.5.2018 09:00 | Tiedote
Karisma Hotels & Resorts, an award-winning luxury hotel collection which owns and manages properties in Latin America, the Caribbean and Europe, is pleased to announce the opening of Allure Palazzi Kotor Bay Hotel by Karisma in June 2018. Built from the ground up in Montenegro’s idyllic Dobrota, the exclusive five-star beachfront property seamlessly blends stunning architecture and design with its mountainous landscape, offering spellbinding views of Kotor Bay. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180517006456/en/ Rendering of Allure Palazzi Kotor Bay (Photo: Business Wire) Sitting on Kotor Bay’s only private beach, the resort features 89 premium guestrooms, 10 villas with private beachfront access, and three breathtaking penthouse suites, each with a balcony or terrace. Allure Palazzi Kotor Bay’s accommodations encompass sumptuous bedding, divine amenities, and carefully selected color palettes bringing the sunny
Siemens Financial Services Selects GTC’s @GlobalTrade Platform for Management of Export Documentary Credits18.5.2018 07:00 | Tiedote
GlobalTrade Corporation (GTC) has announced today that Siemens Financial Services (SFS) has selected its @GlobalTrade Multi-bank Trade Finance Platform for management of its export documentary credits. The platform will be initially rolled out in Germany and thereafter expanded to Siemens entities globally. The system will electronically aggregate all incoming documentary credits in a global database, facilitate review and approval, assist in preparation of compliant documents and enable faster presentation of documents electronically to advising and issuing banks. Gerhard Heubeck, Head of Trade Finance Advisory at Siemens Financial Services, reasons the need for the new system implementation as follows: "After many years of using one of the first standard IT systems available for export documentary credits, the time has come to find a successor tool capable to meet the new requirements such as multi-client capability, processing of new SWIFT message formats, global accessibility, and
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme